CELLATOZ THERAPEUTICS INC has a total of 13 patent applications. It increased the IP activity by 600.0%. Its first patent ever was published in 2017. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are REGENESIS SCIENCE CO LTD, SHENZHEN BIOCAN TECH CO LTD and BREXOGEN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | China | 1 | |
#6 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Analysing materials | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Han Myung-Kwan | 8 |
#2 | Kim Kyeong Kyu | 3 |
#3 | Debojyoti De | 3 |
#4 | Han Myung Kwan | 2 |
Publication | Filing date | Title |
---|---|---|
KR20200124177A | Method for Controlling Selective Differentiation of Musculoskeletal Stem Cell | |
WO2020218845A1 | Method for regulation of selective differentiation of musculoskeletal stem cells | |
KR20190046677A | A Novel Musculoskeletal Stem Cell | |
WO2018160028A1 | Medium composition for neuron differentiation and method for differentiating somatic cells into neurons using same medium composition | |
KR20180101228A | Media composition for differentiation of somatic cell into neuron and differentiation method of somatic cell into neuron using said media composition | |
KR20190063792A | Media composition for differentiation of somatic cell into schwann cell and differentiation method of somatic cell into schwann cell using said media composition |